J. Schaefer Thomas's Insider Trades & SAST Disclosures
J. Schaefer Thomas's most recent trade in Arcadia Biosciences Inc was a trade of 700 Common Stock done at an average price of $2.5 . Disclosure was reported to the exchange on Feb. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern J. Schaefer Thomas.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcadia Biosciences Inc | Thomas J. Schaefer | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.49 per share. | 03 Feb 2025 | 700 | 2,819 (0%) | 0% | 2.5 | 1,743 | Common Stock |
| Arcadia Biosciences Inc | Thomas J. Schaefer | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 20,000 | 25,475 | - | - | Stock Option (Right to Buy) | |
| Arcadia Biosciences Inc | Thomas J. Schaefer | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 01 Aug 2024 | 700 | 2,119 (0%) | 0% | 2.1 | 1,442 | Common Stock |
| Arcadia Biosciences Inc | J. Schaefer Thomas | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.06 per share. | 01 Feb 2024 | 700 | 1,419 (0%) | 0% | 2.1 | 1,442 | Common Stock |
| Arcadia Biosciences Inc | Thomas J. Schaefer | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.67 per share. | 04 Aug 2023 | 649 | 719 (0%) | 0% | 3.7 | 2,382 | Common Stock |
| Arcadia Biosciences Inc | Thomas J. Schaefer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2023 | 1,500 | 5,475 | - | - | Stock Option (Right to Buy) | |
| Arcadia Biosciences Inc | Thomas J. Schaefer | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.23 per share. | 01 Feb 2023 | 700 | 2,800 (0%) | 0% | 0.2 | 161 | Common Stock |
| Arcadia Biosciences Inc | Thomas J. Schaefer | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 50,000 | 159,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges